J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 46(4); 2003 > Article
Heo: Epilepsy: Drug Treatment

Abstract

The prognosis of epilepsy has improved considerably, and about 80% of patients can now be expected to achieve a complete seizure control with antiepileptic drug treatment. It is important to understand that the response to individual drugs may vary considerably in relation to the seizure type or epilepsy syndrome, so that optimization of treatment requires careful individualization of the dosage, and that rational polytherapy should be performed in consideration of the mechanisms of action of antiepileptic drugs, adverse effects, and drug interactions. Although newly developed antiepileptic drugs have some advantages in terms of adverse effects and pharmacokinetics compared with traditional antiepileptic drugs, they have demonstrated no significant difference in efficacy in comparative studies. The purpose of this chapter is to review the basic principles, which should guide the optimal treatment with antiepileptic drugs in patients with epilepsy.

References

1. Deckers CL, Genton P, Sills GJ, Schmidt D. Current limitations of antiepileptic drug therapy: a conference review. Epilepsy Res 2003;53:1–17.

2. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systemic review of their efficacy and tolerability. Epilepsia 1997;38:859–880.

3. Marson AG, Williamson PR, Clough H, Hutton JL, Chadwick DW. Epilepsy Monotherapy Trial Group. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia 2002;43:505–513.

4. Patsalos PN, Froscher W, Pisani F, van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia 2002;43:365–385.

Table 1
jkma-46-287-i001-l.jpg
Table 2
jkma-46-287-i002-l.jpg
Table 3
jkma-46-287-i003-l.jpg
Table 4
jkma-46-287-i004-l.jpg


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul 04427, Korea
Tel: +82-2-6350-6651    Fax: +82-2-792-5208    E-mail: office@jkma.org                

Copyright © 2026 by Korean Medical Association.

Developed in M2PI

Close layer
prev next